Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrially encoded cytochrome b pseudogene 23 (MTCYBP23) is a nuclear pseudogene derived from mitochondrial cytochrome b (MT-CYB). These pseudogenes, known as nuclear mitochondrial DNA segments (NUMTs), are non-functional sequences located in the nuclear genome that exhibit high sequence similarity to functional mitochondrial genes like MT-CYB. MTCYBP23, typical of NUMTs, arises from the evolutionary transfer of mitochondrial DNA fragments into the nuclear genome. It does not produce a functional protein, plays no known biological role, and is not considered a therapeutic target, receptor, enzyme, or transporter. Unlike the functional mitochondrial MT-CYB, MTCYBP23 is not involved in cellular respiration, electron transport, or mitochondrial disease. There are no known drugs, mechanisms of action, or biomarker applications related to MTCYBP23. However, its presence can sometimes confound genetic analyses or mitochondrial disease diagnostics if not accurately distinguished from authentic mitochondrial sequences, posing a challenge in molecular biology.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrially encoded cytochrome b pseudogene 23 (MTCYBP23).